Previous 10 | Next 10 |
John Paulson’s 13F portfolio value increased from $3.21B to $3.85B this quarter. Paulson & Company's largest three positions are Horizon Therapeutics, Bausch Health, and BrightSphere Investment Group. The stake in Barrick Gold was more than doubled during the quarter. ...
Viatris Inc. Hosts Inaugural Investor Day Outlining Unique and Differentiated Business Model, High-Quality Operational Platform, and Focus on CSR and Financial Commitments PR Newswire PITTSBURGH , March 1, 2021 /PRNewswire/ -- At a virtual meeting with the invest...
Implied Volatility in the 3rd percentile is at the same level as it was before the Covid-19 vaccine. Volatility spikes driven by news aren't priced in. Options volatility is also skewed negative and pricing in a $0.10 drop. Historically, this marks great buying opportunities as invest...
The merger proposal for the Mylan-Upjohn tie-up was recent, and the picture they gave there was unsurprisingly rosy. In particular, the dividend picture was attractive. It was known that the company was suffering from a combination of headwinds ranging from Chinese procurement to ...
Otonomy (OTIC) -51% after Otividex fails late-stage Ménière’s disease study.Ebix (EBIX) -32% as auditor resigns after flagging material weakness.Energous (WATT) -20%.MoneyGram International (MGI) -17% on Q4 earnings.Petroleo Brasileiro S.A. - Petrobra...
Viatris (VTRS) sees 2021 revenue in the range of $17.2B to $17.8B vs. a consensus of $18.46B; sees adjusted EBITDA of $6.0B-$6.4B and FCF of $2.0B-$2.3B.The Board expects the Company to pay an annualized dividend of ~$540M, or $0.44 per share.The Company expects the Q1'21 dividend of $0....
Viatris Inc. Announces 2021 Financial Guidance and Reaffirms Strategic and Financial Commitments PR Newswire PITTSBURGH , Feb. 22, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced its 2021 financial guidance and reaffirmed its commitment...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
Viatris Launches Hulio® (adalimumab biosimilar) in Canada Canada NewsWire TORONTO and PITTSBURGH, Feb. 18, 2021 /CNW/ -- Viatris Inc. announced today that Health Canada has approved Hulio ®i , and product is now available in Canada ...
Kahn Brothers’ 13F portfolio value increased from $528M to $579M this quarter. New York Community Bancorp, VOXX International, BlackBerry, and Patterson-UTI Energy were decreased during the quarter. The portfolio continues to be very concentrated with the top five positions...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 12:25:00 ET The late comedian Rodney Dangerfield was famous for his catchphrase, "I don't get no respect." Does Dangerfield's line apply to some stocks today? Absolutely. Three Motley Fool contributors think they've found surprisingly underrated pharmaceutical stocks to b...
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / No country can make every medicine people need, and no medicine is made in every country. If a country or region relies on supply only from within their region and they experience a crisis, there is a risk people won't get the medicines they need, w...
NORTHAMPTON, MA / ACCESSWIRE / July 18, 2024 / Viatris is a global healthcare company focused on bringing high-quality medicines to patients through a hybrid approach that bridges the traditional divide between generics and brands, combining the best of both, to more holistically address healthc...